Cabergoline [kabergolin]
- Terms
-
cabergolin
Dostinex
-
1-((6-allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea
1-Ethyl-2-(3'-dimethylaminopropyl)-3-(6'-allylergoline-8'-beta-carbonyl)urea diphosphate
Cabaser
Cabaseril
Cabergoline Diphosphate
Dostinex
FCE 21336
FCE-21336
Galastop
An ergoline derivative and dopamine D2-agonist that inhibits PROLACTIN secretion. It is used in the management of HYPERPROLACTINEMIA, and to suppress lactation following childbirth for medical reasons. Cabergoline is also used in the management of PARKINSON DISEASE.
- DUI
- D000077465 MeSH Browser
- CUI
- M0136060
- CAS
- Ergoline-8-carboxamide, N-(3-(dimethylamino)propyl)-N-((ethylamino)carbonyl)-6-(2-propen-1-yl)-, (8beta)-
- History note
- 2019 (1985)
- Public note
- 2019; CABERGOLINE was indexed under ERGOLINES 1985-2018
Allowable subheadings
- AD
- administration & dosage 3
- AE
- adverse effects 1
- AG
- agonists 1
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology 2
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 2
- TO
- toxicity
- UR
- urine